Cargando…
SARS-CoV-2 Omicron Variants Reduce Antibody Neutralization and Acquire Usage of Mouse ACE2
Striking number of mutations found in the spike protein of recently emerged SARS-CoV-2 Omicron subvariants BA.1, BA.2, BA.3 and BA.4/5 has raised serious concerns regarding the escape from current antibody therapies and vaccine protection. Here, we conducted comprehensive analysis on the extent of t...
Autores principales: | Wang, Ruoke, Zhang, Qi, Zhang, Rui, Aw, Zhen Qin, Chen, Peng, Wong, Yi Hao, Hong, Junxian, Ju, Bin, Shi, Xuanling, Ding, Qiang, Zhang, Zheng, Chu, Justin Jang Hann, Zhang, Linqi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247160/ https://www.ncbi.nlm.nih.gov/pubmed/35784344 http://dx.doi.org/10.3389/fimmu.2022.854952 |
Ejemplares similares
-
Broadly neutralizing and protective nanobodies against SARS-CoV-2 Omicron subvariants BA.1, BA.2, and BA.4/5 and diverse sarbecoviruses
por: Li, Mingxi, et al.
Publicado: (2022) -
Infection with wild-type SARS-CoV-2 elicits broadly neutralizing and protective antibodies against omicron subvariants
por: Ju, Bin, et al.
Publicado: (2023) -
A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants
por: Shan, Sisi, et al.
Publicado: (2021) -
Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry
por: Ge, Jiwan, et al.
Publicado: (2021) -
Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species
por: Wang, Ruoke, et al.
Publicado: (2021)